- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00958360
Low Vision Intervention Trial II (LOVIT II) (LOVIT II)
July 14, 2016 updated by: VA Office of Research and Development
VA Low Vision Intervention Trial (LOVIT) II
This study will determine if the interdisciplinary team low vision rehabilitation program is more effective than basic low vision care provided by an optometrist working alone in improving visual reading ability in veterans with macular diseases and best corrected visual acuity of 20/50 to 20/200.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Key Questions: The purpose of our proposed single-masked multicenter randomized controlled trial is to determine if the Interdisciplinary Team approach to low vision service delivery is more effective than the Basic Low Vision Service in improving visual reading ability for 330 veterans with macular diseases and best corrected visual acuity of 20/50-20/200.
Effectiveness will be measured with the Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48), a valid and reliable questionnaire that is administered by telephone to capture changes in patients' self-report of their difficulty reading and performing other daily living activities affected by visual impairment before and after rehabilitation.
The primary outcome measure is the comparison of changes in patients' visual reading ability on the VA LV VFQ-48 after they receive low vision care from the Interdisciplinary Team or Basic Low Vision Care program.
The secondary outcome measures are comparisons of changes in other VA LV VFQ-48 visual ability scores (overall, mobility, visual information processing, visual motor skills).
Hypothesis: The improvement in visual reading ability measured with the VA LV VFQ-48 will be larger for patients who received low vision services from the Interdisciplinary Team than for patients who received the Basic Low Vision Service.
Specific Aims:(1) Compare the mean changes in patients' visual reading ability (estimated from patients' difficulty ratings of reading items on the VA LV VFQ-48 before and after low vision service delivery) in the Interdisciplinary Team and Basic Low Vision Care Programs.(2)
Compare the mean changes in visual ability [patients' difficulty ratings of other items on the VA LV VFQ-48 (mobility, visual information processing, visual motor skills) before and after low vision service delivery] in the Interdisciplinary Team and Basic Low Vision Care programs.(3).
Identify the characteristics of patients who benefit from the Interdisciplinary Team and Basic Low Vision Service.
(4).
Conduct an economic evaluation to compare the costs and cost effectiveness of the Interdisciplinary Team and Basic Low Vision Service.
Study Type
Interventional
Enrollment (Actual)
323
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Hines, Illinois, United States, 60141-5000
- Edward Hines Jr. VA Hospital, Hines, IL
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- Cincinnati VA Medical Center, Cincinnati, OH
-
Dayton, Ohio, United States, 45428
- Dayton VA Medical Center, Dayton, OH
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Philadelphia VA Medical Center, Philadelphia, PA
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53705
- William S. Middleton Memorial Veterans Hospital, Madison, WI
-
Milwaukee, Wisconsin, United States, 53295-1000
- Clement J. Zablocki VA Medical Center, Milwaukee, WI
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary eye diagnosis (better seeing Eye) macular disease
- Best-corrected visual acuity (better seeing eye) 20/50-20/200
Exclusion Criteria:
- Does not have a telephone
- Does not speak English
- Has received interdisciplinary low vision services
- English literacy less that 5th grade reading level
- Failed TICS
- Unable or unwilling to attend required clinic visits
- Severe hearing impairment preventing administration of telephone questionnaires
- Planned cataract extraction in next 4 months
- Visual fields contracted to diameter of 20 degrees in better-seeing eye
- Vitreous hemorrhage or serous hemorrhagic detachment of macula
- CNVM treated with fewer than 3 anti-VEGF injections
- Diabetic macular edema (DME) treated with focal/grid laser within the last two months
- DME treated with intravitreal injections of anti-VEGF or intravitreal triamcinolone acetonide (IVTA) within the last two months
- Cystoid macular edema (CME) treated with topical (non-steroidal anti-inflammatory drugs) NSAIDS, topical steroids or IVTA within the last three months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Arm 1
Interdisciplinary Low Vision Rehabilitation: Low vision examination, prescription and dispensing of low vision devices, low vision therapy and homework.
|
Services are provided by optometrist(s) and low vision therapist(s), and include low vision therapy to improve use of remaining vision and low vision devices, and structured homework to practice use of low vision devices that are prescribed and dispensed.
Other Names:
|
ACTIVE_COMPARATOR: Arm 2
Basic Low Vision Care: Low vision examination, prescription and dispensing of low vision devices without low vision therapy or assigned homework.
|
Service is provided by the optometrist alone and includes demonstration of low vision device use and maintenance of prescribed low vision devices, without low vision therapy or homework and with less contact time.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of Changes in Visual Reading Ability From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire
Time Frame: changes from baseline to 4 months later
|
The range of scores for the Visual Reading Ability subscale of the VA Low Vision Visual Functioning Questionnaire is 0 to 3.5 logits (log odds ratio).
A higher score indicates better ability or less difficulty performing activities.
|
changes from baseline to 4 months later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of Changes in Mobility From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire
Time Frame: changes from baseline to 4 months later
|
The range of scores for the Mobility subscale of the VA Low Vision Visual Functioning Questionnaire is 0 to 3.5 logits (log odds ratio).
A higher score indicates better ability or less difficulty performing activities.
|
changes from baseline to 4 months later
|
Comparison of Changes in Visual Information Processing From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire
Time Frame: changes from baseline to 4 months later
|
The range of scores for the Visual Information Processing subscale of the VA Low Vision Visual Functioning Questionnaire is 0 to 3.5 logits (log odds ratio).
A higher score indicates better ability or less difficulty performing activities.
|
changes from baseline to 4 months later
|
Comparison of Changes in Visual Motor Skills From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire
Time Frame: changes from baseline to 4 months later
|
The range of scores for the Visual Motor Skills subscale of the VA Low Vision Visual Functioning Questionnaire is 0 to 3.5 logits (log odds ratio).
A higher score indicates better ability or less difficulty performing activities.
|
changes from baseline to 4 months later
|
Comparison of Overall Visual Ability From Baseline to Four Months Later Measured With 48 Item VA Low Vision Visual Functioning Questionnaire
Time Frame: changes from baseline to 4 months later
|
The range of scores for the Overall Visual Ability subscale of the VA Low Vision Visual Functioning Questionnaire is 0 to 3.5 logits (log odds ratio).
A higher score indicates better ability or less difficulty performing activities.
|
changes from baseline to 4 months later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joan Stelmack, OD MPH, Edward Hines Jr. VA Hospital, Hines, IL
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Stelmack JA, Tang XC, Reda DJ, Stroupe KT, Rinne S, Massof RW; LOVIT II Study Group. VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. Ophthalmic Physiol Opt. 2012 Nov;32(6):461-71. doi: 10.1111/j.1475-1313.2012.00933.x. Epub 2012 Sep 7.
- Stelmack JA, Tang C, Wei Y, Rose K, Ballinger R, Whitman O, Chronister C, Sayers S, Massof RW; LOVIT II Study Group. Veterans Affairs Low-vision Intervention Trial II: One-year Follow-up. Optom Vis Sci. 2019 Oct;96(10):718-725. doi: 10.1097/OPX.0000000000001428.
- Stroupe KT, Stelmack JA, Tang XC, Wei Y, Sayers S, Reda DJ, Kwon E, Massof RW; LOVIT II Study Group. Economic Evaluation of Low-Vision Rehabilitation for Veterans With Macular Diseases in the US Department of Veterans Affairs. JAMA Ophthalmol. 2018 May 1;136(5):524-531. doi: 10.1001/jamaophthalmol.2018.0797. Erratum In: JAMA Ophthalmol. 2018 Aug 1;136(8):959.
- Stelmack JA, Tang XC, Wei Y, Wilcox DT, Morand T, Brahm K, Sayers S, Massof RW; LOVIT II Study Group. Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Feb 1;135(2):96-104. doi: 10.1001/jamaophthalmol.2016.4742.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (ACTUAL)
July 1, 2015
Study Completion (ACTUAL)
September 1, 2015
Study Registration Dates
First Submitted
August 11, 2009
First Submitted That Met QC Criteria
August 12, 2009
First Posted (ESTIMATE)
August 13, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
August 25, 2016
Last Update Submitted That Met QC Criteria
July 14, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C6958-R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Central Vision Loss From Macular Diseases
-
Université de MontréalCanadian Institutes of Health Research (CIHR); Fonds de la Recherche en Santé...TerminatedAge-related Macular Degeneration | Cognitive Impairment | Dementia | Hearing Loss | Low Vision | Low Vision Aids | Reading ProblemCanada
-
Northeastern UniversityNational Eye Institute (NEI); New England College of Optometry; Lighthouse GuildRecruitingAge Related Macular Degeneration | Low VisionUnited States
-
IRCCS San RaffaeleCompletedAge Related Macular DegenerationItaly
-
Johns Hopkins UniversityCompletedNeovascular Age-related Macular Degeneration | Low VisionUnited States
-
Lawson Health Research InstituteUnknownAge-related Macular Degeneration | Low VisionCanada
-
Rabin Medical CenterUnknown
-
Chengdu Kanghong Biotech Co., Ltd.UnknownVery Low Vision Secondary to Wet Age-related Macular DegenerationChina
-
Ocuphire Pharma, Inc.CompletedNight Vision Complaints | Decrease in Night Vision | Disturbance; Vision, LossUnited States
-
Democritus University of ThraceUnknownMacular Edema | Refractive Errors | Low VisionGreece
-
Novartis PharmaceuticalsCompleted
Clinical Trials on Interdisciplinary Low Vision Service
-
Aristotle University Of ThessalonikiRecruitingLow Vision Digital AssistanceGreece
-
US Department of Veterans AffairsCompleted
-
University of California, Los AngelesUniversity of Nebraska; Southern California College of Optometry at Marshall... and other collaboratorsRecruitingLow Vision | Low Vision AidsUnited States
-
Sun Yat-sen University2nd Affilliated Hospital of Fujian Medical UniversityRecruitingArtificial Intelligence | Ophthalmology | Low Vision AidsChina
-
University of California, Los AngelesNational Eye Institute (NEI); New England College of Optometry; American Academy... and other collaboratorsRecruiting
-
New England College of OptometryUniversity of California, Los Angeles; National Institute on Disability, Independent...Completed
-
Optimal Acuity CorporationNot yet recruitingDry Age-related Macular Degeneration | Vision Impairment and Blindness
-
Lawson Health Research InstituteUnknownLow Vision Aids | Low Vision, One Eye, Unspecified Eye | Low Vision BlindnessCanada
-
University of Alabama at BirminghamCompleted
-
University of California, Los AngelesUniversity of Southern CaliforniaRecruiting